Business & startup

  • NHS dementia staff say patients missing out on best care as diagnosis system falls short

    Nearly a quarter of NHS dementia service staff say they cannot provide patients with the best care, while fewer than a third believe diagnostic processes work. Workers are “being let down by a system that isn’t keeping pace with the scale of the challenge”, says a new survey raising concerns about dementia services across the [...]

  • Business roundup: Grant to advance mitochondrial biomarker research

    Age Tech World explores the latest business developments in the world of ageing and longevity. Grant to advance groundbreaking mitochondrial biomarker research Countdown For A Cure, a foundation dedicated to accelerating mitochondrial research and medicine, has announced a US$350,000 grant to Minovia Therapeutics, a clinical-stage company pioneering mitochondrial transplantation technologies. The funding will support Minovia’s [...]

  • Interview: How AI-driven blood test could speed Alzheimer’s diagnosis

    A new plasma technology powered by AI could transform the early detection of Alzheimer's Disease. Agetech World speaks to Cognitac CEO Stella Ling to find out more. Existing blood-based biomarkers for Alzheimer's disease (AD) mainly focus on its pathological features such as amyloid-beta (Aβ) and tau protein pathology, however, tests for other biomarkers are limited - making [...]

  • Dementia patients waiting to two years for diagnosis, study reveals

    Patients in England are waiting up to two years for a dementia diagnosis, with average delays increasing by more than a third since 2019, a new report has revealed. Average waits from referral to diagnosis have risen from 13 weeks in 2019 to 17.7 weeks, while maximum waits have grown from 34 weeks to two [...]

  • Sir Alex Ferguson backs dementia music charity

    Sir Alex Ferguson has become ambassador for Playlist for Life, a dementia charity using personalised music to improve the lives of people with memory conditions. The former Manchester United and Aberdeen manager visited the charity’s Glasgow office this week to learn how music therapy supports people living with dementia. He also shared his own playlist [...]

  • Weight-loss focus may harm obesity patients, experts warn

    Focusing only on weight loss in people with obesity could cause more harm than good, medical experts have said. Standard advice to eat less and exercise more often fails to deliver sustained weight loss and may reinforce harmful weight stigma. Although widely promoted, these strategies have shown limited long-term benefits for reducing events such as [...]

  • Air pollution cuts UK life expectancy by nearly two years – study

    Air pollution is shortening UK life expectancy by 1.8 years and is linked to more than 500 deaths every week, with costs to the NHS and economy exceeding £500m weekly, new research has found. Toxic air, inhaled by 99 per cent of the population, causes damage to almost every organ – even at low levels [...]

  • NHS rejects Alzheimer’s drugs over cost concerns

    Two new Alzheimer’s drugs have been rejected for NHS use after health officials said the benefits were too limited to justify potential costs of up to £1bn a year. Donanemab and lecanemab are antibody-based treatments that target the underlying cause of Alzheimer’s disease, rather than only managing symptoms. They work by binding to amyloid – [...]

  • Jersey considers age-friendly planning for older residents

    Politicians in Jersey are calling for new planning policies, including “10-minute neighbourhoods”, to support the island’s rapidly ageing population. Deputy Inna Gardiner has lodged a proposition to create an “age-friendly infrastructure framework” aimed at adapting planning standards to better support older people. The framework proposes keeping GPs, pharmacies, shops and parks within walking distance, alongside [...]

  • NHS Scotland rejects new Alzheimer’s drug donanemab, dealing blow to dementia treatment hopes

    A woman living with Alzheimer's disease has said dementia research has suffered a "devastating blow" after a new treatment was rejected for use by NHS Scotland. Donanemab, a drug designed to slow the onset of dementia, works by targeting one of the causes of the disease, rather than just treating its symptoms. But the Scottish [...]